glp 1 investment GLP-1 Agonists Weight Loss Drugs Market Report, 2025-2030 The Skinny on GLP-1 Investing

This medical device is registered to provide accurate readings, allowing our doctor to diagnose SIBO and IMO based on your results

This sets up the possibility that Medicare beneficiaries could have coverage of GLP-1s for obesity under the Medicare GLP-1 Bridge in the latter half of 2026 and 2027 but then lose access in 2028 if the BALANCE Model or another coverage pathway are not implemented

SoWell Protein uses whey protein isolate, which has all the positives of whey protein without gut-disrupting lactose

Gradual reintroduction of soluble fiber (such as oats or psyllium) after initial symptom control supports long-term digestive health and may help prevent constipation, which can contribute to bloating

But once the medication kicks in and their overall food intake decreases, the traditional half a plate of vegetables model often doesnt fit anymore